CXCL13 and Schnyder corneal dystrophy: Inflammation antibody microarray results are presented in Figure 8 showing that markers B-lymphocyte chemoattractant (BLC), fractalkine (TNFSF8), granulocyte–macrophage colony-stimulating factor (GM-CSF), IL-1α, IL-6, IL-12-p70, IL-13, lymphotactin (XCL1), monocyte chemoattractant protein (MCP)-1, macrophage colony-stimulating factor (M-CSF), monokine induced by gamma interferon (MIG), stromal cell-derived factor (SDF)-1, C-C motif ligand (CCL) 1, and TNF-α were expressed in cells treated with LPS and SCD of variety GN1 (Figure 8A).